Association Between Serum G Protein-Coupled Estrogen Receptor and the Peripheral Blood Balance of T-Helper/New Effector T-Cells in Patients With Hashimoto's Thyroiditis. [PDF]
Zang X +6 more
europepmc +1 more source
Nonclinical regulatory considerations for investigational new drug applications for regulatory T cell therapies. [PDF]
Dinh PU, Mihalcik L.
europepmc +1 more source
Related searches:
Treg cells in autoimmunity: from identification to Treg-based therapies
Seminars in Immunopathology, 2019Regulatory (Treg) cells are key regulators of inflammation and important for immune tolerance and homeostasis. A major progress has been made in the identification and classification of Treg cells. Due to technological advances, we have gained deep insights in the epigenetic regulation of Treg cells. The use of fate reporter mice allowed addressing the
L. Göschl, C. Scheinecker, M. Bonelli
semanticscholar +3 more sources
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
Jay Y Spiegel +2 more
exaly +2 more sources
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
Regulatory T cells (Treg cells) maintain host self-tolerance but are a major barrier to effective cancer immunotherapy. Treg cells subvert beneficial anti-tumor immunity by modulating inhibitory receptor expression on tumor-infiltrating lymphocytes (TILs)
Deepali V Sawant +2 more
exaly +2 more sources
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Nature, 2013Koji Atarashi +2 more
exaly +2 more sources
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Regulatory T (Treg) cells suppress abnormal/excessive immune responses to self‐ and nonself‐antigens to maintain immune homeostasis. In tumor immunity, Treg cells are involved in tumor development and progression by inhibiting antitumor immunity.
Yoshihiro Ohue, Hiroyoshi Nishikawa
exaly +2 more sources
When worlds collide: Th17 and Treg cells in cancer and autoimmunity
Hannah M Knochelmann +2 more
exaly +2 more sources
Atherosclerosis involves both innate and adaptive immunity. Here, we provide an overview of the role of regulatory T (Treg) cells in atherosclerotic diseases. Treg cells and their inhibitory cytokines, IL-10 and TGF-β, have been identified in atherosclerotic lesions and to inhibit progression through lipoprotein metabolism modulation.
Rebecca Kuan +2 more
openaire +2 more sources
Intratumoral regulatory T (Treg) cell abundance associates with diminished antitumor immunity and poor prognosis in human cancers. Recent work demonstrates that CD25, the high-affinity receptor subunit for interleukin (IL)-2, is a selective target for ...
Ehsan Ghorani +2 more
exaly +2 more sources

